Active

BioVentures Investors

Investor type

PE / VC

Founded

1998

AUM

$200 M

Location

Boston, Massachusetts, United States

Investment Ticket

$10-50 m

Investment Stage

Seed Series A Series B Late Stage (Series C+)

Region of investment

North America
Investor profile last updated: 09 February, 2026

Profile

ADVANCING THE GROWTH OF MEDTECH:
We are partner with the innovators who are changing the practice of medicine. BioVentures MedTech Funds invests in companies that are developing today's leading-edge biomedical technologies. Together, we create dynamic solutions that improve health outcomes and reduce the cost of care.

Industry

Biotechnology Healthcare Services Medical Devices Software MedTech Life Sciences Infrastructure HealthTech Digital

BioVentures Investors Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
BioVentures Investors IV, LP
Venture Capital (VC)
Biotechnology
Digital
Healthcare Services
Medical Devices
HealthTech
Pre-seed
Seed
North America
$5-10 m
$87 M
October 2016

Contacts

Name
Title
Email
avatar
Jonathan Gertler Senior Director
Senior Director
j•••@•••
avatar
Marc Goldberg General Partner
General Partner
-
Upgrade to see contacts
avatar
TLn3mQs6O2G4f9eP TLn3mQs6O2G4f9eP
TLn3mQs6O2G4f9eP
avatar
TLn3mQs6O2G4f9eP TLn3mQs6O2G4f9eP
TLn3mQs6O2G4f9eP
avatar
TLn3mQs6O2G4f9eP TLn3mQs6O2G4f9eP
TLn3mQs6O2G4f9eP
Investment-team contacts for BioVentures Investors — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about BioVentures Investors

BioVentures Investors is a venture capital and private equity firm. It backs companies at Seed, Series A, Series B and Late Stage (Series C+), writing tickets of $10-50 m.
BioVentures Investors is located in Boston, Massachusetts, United States.
BioVentures Investors was founded in 1998.
BioVentures Investors invests in companies and startups in Biotechnology, Healthcare Services, Medical Devices, Software, MedTech, Life Sciences, Infrastructure, HealthTech, Digital.
BioVentures Investors invests in companies and startups in North America.
BioVentures Investors invests in companies and startups at Seed, Series A, Series B, Late Stage (Series C+).
BioVentures Investors usually invests $10-50 m on average.
BioVentures Investors has around $200m assets under management.
BioVentures Investors last fund was created/launched in 2016-10-07
BioVentures Investors can be reached through its website bioventuresinvestors.com and its LinkedIn page. Its general enquiries address is info@bioventuresinvestors.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for BioVentures Investors — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query BioVentures Investors directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 09 February, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.